Sign In
Free Newsletter
J&J cutting 56 jobs at New Brunswick HQ
The layoffs at the pharmaceutical giant come amid plans to separate Johnson & Johnson's orthopedic business.
HINJ forum highlights NJ life sciences, innovation economy
Featuring Gov. Mikie Sherrill and others, the forum showcased the state's life sciences leadership, connecting industry, policymakers and researchers to drive innovation and economic growth.
NJ Evergreen Fund invests $4.65M in five startups
The New Jersey Economic Development Authority investments aim to boost tech and life sciences, as well as support growth and innovation in New Jersey.
Johnson & Johnson hits $100M medtech donation milestone
Johnson & Johnson announced $100 million in medtech donations since 2020 and plans an additional $20 million in 2026 to expand global access to care.
NJEDA approves $12.5M for medtech, maternal health hubs
The funding approved by the New Jersey Economic Development Authority will help support two Strategic Innovation Centers focused on medical technology and maternal and infant health statewide.
NJ hospitals, medtech firms drive cardiac innovation
Health care providers and companies are employing AI, wearables – and partnerships – to improve heart care and patient outcomes.
Lura Health partners with Japan’s SCO Group on Asia expansion
The HAX startup will work to expand the reach of its salivary biosensor tech, advancing preventative care and clinical integration.
BD invests $35M to expand syringe plant in Nebraska
The move builds on the Franklin Lakes-based medical technology company's broader commitment to strengthen U.S. health care infrastructure and ensure long-term supply resilience.
NJ unveils medtech innovation center plans in South Jersey
The NJEDA will partner with Rowan University to grow startups and boost the sector in the region with dedicated locations planned for Camden and Mullica Hill.
NJBIZ Best Places to Work winner will be acquired for $1.65B
A tech leader in autism and intellectual and development disabilities care, CentralReach's move will help position the company for even greater growth.
Reports: Johnson & Johnson aims to sell stroke care business for over $1B (updated)
The potential move comes as the New Brunswick-based health care giant continues to reorganize its medical technology division.
Medtech mindset: BD plans to divest diagnostic, biosciences divisions
According to the company, medical essentials and interventional lead the medical technology unit's business lines, bringing in about $6.2 billion and $5 billion, respectively.
